MindWalk Holdings

MindWalk AI (formerly ImmunoPrecise Antibodies Ltd.) operates a hybrid biotherapeutic research and discovery platform that combines laboratory and computational technologies to support antibody discovery and development for pharmaceutical partners. The company’s services include full-continuum therapeutic antibody screening, characterization and optimization, supported by AI-driven in silico tools and machine intelligence workflows. MindWalk AI maintains offices in North America and Europe and positions its technology stack to address complex target challenges in biologics research.